cyproterone acetate has been researched along with 4-(3,4,4-trimethyl-5-oxo-2-thioxo-1-imidazolidinyl)-2-(trifluoromethyl)benzonitrile in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaillard, M; Matias, JR | 1 |
| André, J; Foury, O; Joly-Pharaboz, MO; Nicolas, B | 1 |
2 other study(ies) available for cyproterone acetate and 4-(3,4,4-trimethyl-5-oxo-2-thioxo-1-imidazolidinyl)-2-(trifluoromethyl)benzonitrile
| Article | Year |
|---|---|
Local inhibition of sebaceous gland growth by topically applied RU 58841.
Topics: Administration, Topical; Androgen Antagonists; Animals; Cricetinae; Cyproterone Acetate; Ear; Imidazoles; Indenes; Male; Mesocricetus; Models, Biological; Nitriles; Sebaceous Glands; Structure-Activity Relationship; Time Factors | 1995 |
Control of the proliferation of prostate cancer cells by an androgen and two antiandrogens. Cell specific sets of responses.
Topics: Androgen Antagonists; Cell Division; Cyproterone Acetate; Genes, myc; Humans; Imidazoles; Kinetics; Male; Metribolone; Nitriles; Prostatic Neoplasms; Proto-Oncogene Proteins c-myc; RNA, Messenger; Testosterone Congeners; Transcription, Genetic; Tumor Cells, Cultured | 1998 |